Cargando…
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
Liposome-encapsulation has been suggested as method to improve the efficacy of ciprofloxacin against the intracellular pathogen, Francisella tularensis. Early work with a prototype formulation, evaluated for use against the F. tularensis live vaccine strain, showed that a single dose of liposomal ci...
Autores principales: | Hamblin, Karleigh A., Wong, Jonathan P., Blanchard, James D., Atkins, Helen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062069/ https://www.ncbi.nlm.nih.gov/pubmed/24995163 http://dx.doi.org/10.3389/fcimb.2014.00079 |
Ejemplares similares
-
Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague
por: Hamblin, Karleigh A., et al.
Publicado: (2017) -
Neutrophils: potential therapeutic targets in tularemia?
por: Allen, Lee-Ann H.
Publicado: (2013) -
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug
por: Cipolla, David, et al.
Publicado: (2016) -
Development of Liposomal Ciprofloxacin to Treat Lung Infections
por: Cipolla, David, et al.
Publicado: (2016) -
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
por: Barnes, Kay B., et al.
Publicado: (2019)